I check in with Graham Collins (University of Oxford), David Steensma (Dana Farber Cancer Institute), and Vincent Rajkumar (Mayo Clinic) to discuss the most prevalent and noteworthy clinical research from the virtual EHA meeting discussing recent advances in Hodgkin lymphoma, MDS and AML, multiple myeloma, and DLBCL. You were unable to travel there, but you can listen to the recent advances.
Observations and Commentary on Medicine and Current Events
